Schizophrenia Research
Volume 98, Issue 1 , Pages 84-88, January 2008

Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia

  • Mechteld L.C. Hoogendoorn

      Affiliations

    • Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 302501783, +31 302523219; fax: +31 302505443.
    • Both authors contributed equally to this study.
  • ,
  • Jacob A.S. Vorstman

      Affiliations

    • Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
    • Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA
    • Both authors contributed equally to this study.
  • ,
  • Gholam R. Jalali

      Affiliations

    • Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA
  • ,
  • Jean-Paul Selten

      Affiliations

    • Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
  • ,
  • Richard J. Sinke

      Affiliations

    • Complex Genetics Section, Department of Biomedical Genetics, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands
  • ,
  • Beverly S. Emanuel

      Affiliations

    • Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA
  • ,
  • René S. Kahn

      Affiliations

    • Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands

Received 14 June 2007; received in revised form 8 September 2007; accepted 18 September 2007. published online 29 October 2007.

Abstract 

The objectives of this study were 1) to examine whether the prevalence of 22q11.2 deletion syndrome (22q11DS) in schizophrenia patients with the Deficit syndrome is higher than the reported ∼2% for the population of schizophrenia patients as a whole, and 2) to estimate the overall prevalence of 22q11DS among schizophrenia patients by combining all available studies. Our sample, enriched for patients with the Deficit syndrome, had 88% power to detect an estimated prevalence of 5% of 22q11.2 deletions. No 22q11.2 deletions were detected in 311 schizophrenia patients, 146 of whom met criteria for the Deficit syndrome. Our literature research revealed that in eight studies sixteen deletions were identified in 2133 patients with schizophrenia. This corresponds to a prevalence of 0.75% (95%CI: 0.5%–1.2%). In conclusion: The prevalence of 22q11.2DS in schizophrenia patients with the Deficit syndrome is not higher than in the population of schizophrenia patients as a whole. The prevalence of 22q11.2DS in schizophrenia patients is lower than the frequently reported prevalence of 2% or more.

Keywords: 22q11 deletion syndrome, 22q11DS, Schizophrenia, VCFS, Deficit syndrome, Prevalence

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-9964(07)00430-6

doi:10.1016/j.schres.2007.09.025

Schizophrenia Research
Volume 98, Issue 1 , Pages 84-88, January 2008